Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Dec;96(6):2975–2979. doi: 10.1172/JCI118369

Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction.

Y Oike 1, A Hata 1, Y Ogata 1, Y Numata 1, K Shido 1, K Kondo 1
PMCID: PMC186009  PMID: 8675669

Abstract

It has been reported that individuals with the D allele of an insertion/deletion (I/D) polymorphism of the angiotensin converting enzyme (ACE) gene are at greater risk for myocardial infarction (MI), especially among subjects normally considered to be at low risk. However, little is known about the mechanism by which the ACE polymorphism affects the risk of MI. Coronary artery spasm (CAS) is considered to be one possible mechanism for developing MI. We therefore examined the ACE polymorphism relation to CAS to determine if this was the mechanism by which the DD genotype influences MI. We studied 150 angiographically assessed Japanese males, all more than 60 yr old. CASs were detected using intracoronary injection of ergonovine maleate. Subjects were divided into three groups: those with CAS (group 1), those without CAS, but with fixed organic stenosis (group 2); and those without CAS and no organic stenosis (group 3). DD subjects were significantly represented in group 1 when compared with groups 2 (P = 0.002) and 3 (P = 0.026). These results suggest that the DD genotype relates to the greater risk for MI in the patients with CAS.

Full text

PDF
2975

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonnardeaux A., Davies E., Jeunemaitre X., Féry I., Charru A., Clauser E., Tiret L., Cambien F., Corvol P., Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994 Jul;24(1):63–69. doi: 10.1161/01.hyp.24.1.63. [DOI] [PubMed] [Google Scholar]
  2. Bøhn M., Berge K. E., Bakken A., Erikssen J., Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet. 1993 Dec;44(6):292–297. doi: 10.1111/j.1399-0004.1993.tb03903.x. [DOI] [PubMed] [Google Scholar]
  3. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  4. Caralis D. G., Deligonul U., Kern M. J., Cohen J. D. Smoking is a risk factor for coronary spasm in young women. Circulation. 1992 Mar;85(3):905–909. doi: 10.1161/01.cir.85.3.905. [DOI] [PubMed] [Google Scholar]
  5. Dzau V. J. Significance of the vascular renin-angiotensin pathway. Hypertension. 1986 Jul;8(7):553–559. doi: 10.1161/01.hyp.8.7.553. [DOI] [PubMed] [Google Scholar]
  6. Egashira K., Inou T., Yamada A., Hirooka Y., Takeshita A. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest. 1992 Mar;89(3):1047–1052. doi: 10.1172/JCI115646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Endo M., Hirosawa K., Kaneko N., Hase K., Inoue Y. Prinzmetal's variant angina. Coronary arteriogram and left ventriculogram during angina attack induced by methacholine. N Engl J Med. 1976 Jan 29;294(5):252–255. doi: 10.1056/NEJM197601292940505. [DOI] [PubMed] [Google Scholar]
  8. Fukai T., Egashira K., Hata H., Numaguchi K., Ohara Y., Takahashi T., Tomoike H., Takeshita A. Serotonin-induced coronary spasm in a swine model. A minor role of defective endothelium-derived relaxing factor. Circulation. 1993 Oct;88(4 Pt 1):1922–1930. doi: 10.1161/01.cir.88.4.1922. [DOI] [PubMed] [Google Scholar]
  9. Iwai N., Ohmichi N., Nakamura Y., Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994 Dec;90(6):2622–2628. doi: 10.1161/01.cir.90.6.2622. [DOI] [PubMed] [Google Scholar]
  10. Kasahara Y., Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem. 1981 Nov;27(11):1922–1925. [PubMed] [Google Scholar]
  11. Kato H., Iwai N., Inui H., Kimoto K., Uchiyama Y., Inagami T. Regulation of vascular angiotensin release. Hypertension. 1993 Apr;21(4):446–454. doi: 10.1161/01.hyp.21.4.446. [DOI] [PubMed] [Google Scholar]
  12. Lindpaintner K., Pfeffer M. A., Kreutz R., Stampfer M. J., Grodstein F., LaMotte F., Buring J., Hennekens C. H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995 Mar 16;332(11):706–711. doi: 10.1056/NEJM199503163321103. [DOI] [PubMed] [Google Scholar]
  13. Ludwig E., Corneli P. S., Anderson J. L., Marshall H. W., Lalouel J. M., Ward R. H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995 Apr 15;91(8):2120–2124. doi: 10.1161/01.cir.91.8.2120. [DOI] [PubMed] [Google Scholar]
  14. Maseri A., Davies G., Hackett D., Kaski J. C. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation. 1990 Jun;81(6):1983–1991. doi: 10.1161/01.cir.81.6.1983. [DOI] [PubMed] [Google Scholar]
  15. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A. M., Severi S., Parodi O., Biagini A., Distante A. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978 Dec 7;299(23):1271–1277. doi: 10.1056/NEJM197812072992303. [DOI] [PubMed] [Google Scholar]
  16. Mattu R. K., Needham E. W., Galton D. J., Frangos E., Clark A. J., Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995 Jan 15;91(2):270–274. doi: 10.1161/01.cir.91.2.270. [DOI] [PubMed] [Google Scholar]
  17. Morishita R., Gibbons G. H., Ellison K. E., Lee W., Zhang L., Yu H., Kaneda Y., Ogihara T., Dzau V. J. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994 Sep;94(3):978–984. doi: 10.1172/JCI117464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakai K., Itoh C., Miura Y., Hotta K., Musha T., Itoh T., Miyakawa T., Iwasaki R., Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994 Nov;90(5):2199–2202. doi: 10.1161/01.cir.90.5.2199. [DOI] [PubMed] [Google Scholar]
  19. Nobuyoshi M., Abe M., Nosaka H., Kimura T., Yokoi H., Hamasaki N., Shindo T., Kimura K., Nakamura T., Nakagawa Y. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J. 1992 Jul;124(1):32–38. doi: 10.1016/0002-8703(92)90917-k. [DOI] [PubMed] [Google Scholar]
  20. Okamura T., Miyazaki M., Inagami T., Toda N. Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension. 1986 Jul;8(7):560–565. doi: 10.1161/01.hyp.8.7.560. [DOI] [PubMed] [Google Scholar]
  21. Oliva P. B., Breckinridge J. C. Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation. 1977 Sep;56(3):366–374. doi: 10.1161/01.cir.56.3.366. [DOI] [PubMed] [Google Scholar]
  22. Oliva P. B., Potts D. E., Pluss R. G. Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. N Engl J Med. 1973 Apr 12;288(15):745–751. doi: 10.1056/NEJM197304122881501. [DOI] [PubMed] [Google Scholar]
  23. Paul M., Wagner J., Dzau V. J. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest. 1993 May;91(5):2058–2064. doi: 10.1172/JCI116428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rakugi H., Kim D. K., Krieger J. E., Wang D. S., Dzau V. J., Pratt R. E. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest. 1994 Jan;93(1):339–346. doi: 10.1172/JCI116965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343–1346. doi: 10.1172/JCI114844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SONES F. M., Jr, SHIREY E. K. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962 Jul;31:735–738. [PubMed] [Google Scholar]
  27. Scholl J. M., Benacerraf A., Ducimetiere P., Chabas D., Brau J., Chapelle J., Thery J. L. Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina. Am J Cardiol. 1986 Feb 1;57(4):199–202. doi: 10.1016/0002-9149(86)90890-8. [DOI] [PubMed] [Google Scholar]
  28. Schunkert H., Dzau V. J., Tang S. S., Hirsch A. T., Apstein C. S., Lorell B. H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990 Dec;86(6):1913–1920. doi: 10.1172/JCI114924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shanmugam V., Sell K. W., Saha B. K. Mistyping ACE heterozygotes. PCR Methods Appl. 1993 Oct;3(2):120–121. doi: 10.1101/gr.3.2.120. [DOI] [PubMed] [Google Scholar]
  30. Sugiishi M., Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993 Jan;87(1):76–79. doi: 10.1161/01.cir.87.1.76. [DOI] [PubMed] [Google Scholar]
  31. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., Arveiler D., Luc G., Kee F., Ducimetière P. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994 Oct 1;344(8927):910–913. doi: 10.1016/s0140-6736(94)92268-3. [DOI] [PubMed] [Google Scholar]
  32. Vanhoutte P. M., Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 1989 Jul;80(1):1–9. doi: 10.1161/01.cir.80.1.1. [DOI] [PubMed] [Google Scholar]
  33. Yamamoto H., Yoshimura H., Noma M., Kai H., Suzuki S., Tajimi T., Sugihara M., Kikuchi Y. Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P. Am Heart J. 1992 Feb;123(2):298–303. doi: 10.1016/0002-8703(92)90638-c. [DOI] [PubMed] [Google Scholar]
  34. Yasue H., Horio Y., Nakamura N., Fujii H., Imoto N., Sonoda R., Kugiyama K., Obata K., Morikami Y., Kimura T. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation. 1986 Nov;74(5):955–963. doi: 10.1161/01.cir.74.5.955. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES